N/A N=38 Cannabidiol and Emotional Stimuli
Drug Addiction
Primary: Positivity Ratings of Social Images — 1.96; 1.68; 1.86; 1.93 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=6,097 S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Breast Cancer
Primary: Disease-free Survival — 88; 88; 87 percentage of analyzed participants — p=0.49
Phase 1 N=16 GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects
Pulmonary Disease, Chronic Obstructive
Primary: Area Under the Concentration-time Curve From Time 0 to Infinity (AUC [0-inf]) of Danirixin for Part 1 — 6166.7; 6052.9; 5816.4; 5996.1 Hours*nanograms per milliliter
N/A N=175 The Relationship of Platelet Micro-RNA Expression and Platelet Reactivity in Patients Under Clopidogrel or Ticagrelor Treatment
PRU · miRNA
Primary: miRNA — -8.14; -3.46; -7.54; -3.97 fold of change
Phase 2 N=32 Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.
Lung Transplant Infection · Lower Respiratory Tract Infection
Primary: Lung Clearance Index 2% (LCI2%) — 10.68; 11.65; 10.09; 11.19 Index (change)
N/A N=16 Desaturation Validation of INVSENSOR00009
Healthy
Primary: Trending Regional Oxygen Saturation Accuracy of the INVSENSOR00009 Relative to the Control Sensor by Arms Calculation — 1.3 % tissue oxygen saturation
Phase 2 N=350 A Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis
Knee Osteoarthritis · Medial Compartment Knee Osteoarthritis
Primary: Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Scores of the Index Knee at Week 16 — -8.9; -9.2; -11.8; -10.1 score…
Phase 3 N=558 Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
Arthritis, Rheumatoid
Primary: Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 22 — 68.1; 59.1 percentage of participants
Phase 2 N=3 Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Primary: Overall Survival Rate — 0 percentage of participants alive
N/A N=224 Effects of a Rheumatoid Arthritis Self-management Program
Arthritis, Rheumatoid
Primary: Disease Activity — 3.38; 3.62 score on a scale
Phase 1 N=30 Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors
Tumors
Primary: AUC(0-24): Area Under the Concentration-time Curve From Time Zero to 24 Hours Postdose for Midazolam and 1'-Hydroxymidazolam — 92.5; 89.7; 117; 38.5 hour*nanograms per…
N/A N=42 New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
HIV Infections
Primary: Combined Endpoint Including HIV RNA and HIV DNA — 0; 0 Participants
Phase 1 N=18 A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy Volunteers
Malaria
Primary: Cmax: Peak Plasma Concentration — 277; 373.4444 ng/mL
N/A N=211 Sequenced Therapies for Comorbid and Primary Insomnias
Insomnia Comorbid to Psychiatric Disorder · Primary Insomnia
Primary: Percent of Participants Who Met Remission as Measured by the Insomnia Severity Index — 40.00; 34.94; 37.04; 48.15 percent remitted
Phase 3 N=93 Phase III Confirmatory Study in Erythropoietic Protoporphyria
Erythropoietic Protoporphyria
Primary: Duration of Direct Sunlight Exposure Between 10:00 and 18:00 Hours on Days When no Pain Was Experienced (Pain Score of 0). — 69.4; 40.8 hours